Oncology Data Articles
-
Generic Sterile Injectable Market is anticipated to progress at a CAGR of 7.1% by 2032
The Generic Sterile Injectable market report enables the product offering to be improved. It then moves on to innovative concepts for boosting profitability and productivity in the workplace. It also provides a few useful suggestions for assessing business performance. To understand more about the current industry condition, prioritized data is also accessible. This Generic Sterile Injectable ...
By insightSLICE
-
AngioDynamics and Cardiva Expand Partnership to Bring Life-Saving Products to More Patients in Europe
We are pleased to announce an expanded partnership with Cardiva, a Spanish-based medical device company. The partnership builds on an existing collaboration between AngioDynamics and Cardiva, which has seen the successful distribution of AngioDynamics’ vascular access portfolio in Spain and Portugal since 2012. The expanded partnership will now include AngioDynamics’ oncology ...
-
Key Takeaways from BIO 2022 for AI-enabled Drug Discovery
It was great to be back in person at the 2022 BIO International Convention this year. It came as no surprise to us at Recursion that artificial intelligence (AI) and machine learning (ML) were hot topics at the conference, with more than half a dozen sessions exploring how these technologies are driving digital transformation in biopharma. We heard from leaders who are applying AI at ...
By Recursion
-
What Clinical Trial Speed Factors Can Sponsors Actually Control?
When promising drug candidates are identified for further investigation in clinical trials, sponsor companies are usually optimistic about outcomes. But there are times, when after years of sunk effort and resources, clinical trials fail to bring a viable drug to market. Frequently, a drug fails for safety or efficacy reasons that are beyond a sponsor’s control. However, to some degree, ...
-
RNA Sequencing Increases the Chance of RNA Biomarker Discovery
Biomarkers are defined as measurable biological characteristics that are associated with normal or pathological conditions. They possess clinical relevance, including diagnostic, prognostic, and predictive values. RNA, not only an essential part of the central dogma, is certainly a relatively untapped resource for biomarker discovery of various diseases. Cumulating data shows that RNA ...
By CD Genomics
-
Mapk4 May Be a New Target for the Treatment of Triple-Negative Breast Cancer
There is now growing evidence that the MAPK4 enzyme may be involved in cancer growth and resistance to specific therapies. Recently, an article titled " MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade" was published in Nature Communications. By analyzing public genome databases, the researchers found that a large number of triple-negative ...
-
Upgrades to Our Cancer Model Database - Case Study
We've added over 125 new datasets to our Cancer Model Database. It provides access to a comprehensive collection of well-established tumor models for early-stage oncology research and increases their translational capabilities to the clinic. The update adds new patient-derived xenograft (PDX) models for several cancer types, including anal, colon, kidney, renal, and leukemia. Additionally, this ...
-
Mesothelioma treatment options: patient medical research & pain management
Mesothelioma Treatment Options: Patient Medical Research & Pain Management 1) Keep up an open dialogue with your doctor It is natural to want to understand as much as possible about a disease and its treatments, particularly when the disease is as rare as malignant mesothelioma. The Internet has opened up a wealth of information on mesothelioma, however, it is still important to keep in ...
-
A database of cancer induction by low-dose radiation in mammals: overview and initial observations
The lifespan studies of animals exposed to low doses of ionizing radiation with a view to determining the relationships between radiation dose and cancer incidence have been identified and corresponding publications have been reviewed. The information on experimental conditions and cancer incidence data in exposed and control animals have been entered into a database intended for a global ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you